Literature DB >> 6827135

Postnatal infectivity of hepatitis B surface antigen-carrier mothers.

R P Beasley, L Y Hwang.   

Abstract

The incidence of hepatitis B virus (HBV) infections during the second and third year of life was determined for 105 children whose mothers were carriers of hepatitis B surface antigen. Children were given hepatitis B immune globulin (HBIG) at birth and in some instances three and six months later to protect against HBV infection. Passive antibodies from the dose of HBIG disappeared in three to four months. Infants negative for HBV markers at 12 months were selected and subsequent infections were analyzed in relation to the e system markers in the mother. Over an average of 17.5 months of follow-up, 38.1% of the infants became infected, an annual incidence rate of 26.0%. The rate was highest for children whose mothers were positive for hepatitis B e antigen (HBeAg) (57.1%), moderate for those whose mothers were negative for both HBeAg and antibody to HBeAg (anti-HBe) (20.4%), and lowest for those whose mothers were positive for anti-HBe (11.3%).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6827135     DOI: 10.1093/infdis/147.2.185

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  45 in total

1.  Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers.

Authors:  Y Poovorawan; S Sanpavat; S Chumdermpadetsuk; A Safary
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

2.  Comparison of the nucleic acid-based crosslinking hybridization assay and the branched DNA signal amplification assay in the quantitative measurement of serum hepatitis B virus DNA.

Authors:  S J Hwang; R H Lu; M L Wood; Y J Wang; F Y Chang; S D Lee
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

3.  Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission.

Authors:  Manisha Dwivedi; Sri Prakash Misra; Vatsala Misra; Arvind Pandey; Sanjay Pant; Rita Singh; Manju Verma
Journal:  Indian J Gastroenterol       Date:  2011-04-16

4.  Structural analysis of hepatitis B surface antigen by monoclonal antibodies.

Authors:  E Ben-Porath; J R Wands; R A Marciniak; M A Wong; L Hornstein; R Ryder; M Canlas; A Lingao; K J Isselbacher
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

5.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Authors:  Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong
Journal:  Hepatology       Date:  2018-04       Impact factor: 17.425

6.  Epidemiology of childhood hepatitis B in India: vaccination related issues.

Authors:  L Kant; A J Hall
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

Review 7.  Chronic viral hepatitis.

Authors:  M H Chang
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

8.  Screening of pregnant women for hepatitis B markers in a French Provincial University Hospital (Limoges) during 15 years.

Authors:  François Denis; Sylvie Ranger-Rogez; Sophie Alain; Marcelle Mounier; Caroline Debrock; Anne Wagner; Christian Delpeyroux; Jean Louis Tabaste; Yves Aubard; Pierre-Marie Preux
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 9.  Hepatitis B in pregnancy.

Authors:  J A Arevalo
Journal:  West J Med       Date:  1989-06

10.  Should hepatitis B surface antigen positive mothers breast feed?

Authors:  M de Martino; C Appendino; M Resti; M E Rossi; A T Muccioli; A Vierucci
Journal:  Arch Dis Child       Date:  1985-10       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.